| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/PACE.12588 |
| P8608 | Fatcat ID | release_3q5j3ousybgohkwhmap2gxoc2a |
| P698 | PubMed publication ID | 25626468 |
| P50 | author | Anne-Sophie Jannot | Q56863175 |
| P2093 | author name string | François Mach | |
| Haran Burri | |||
| Henri Sunthorn | |||
| Elena Tessitore | |||
| Dipen Shah | |||
| Pascale Gentil-Baron | |||
| Van Nam Tran | |||
| P2860 | cites work | Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? | Q28166299 |
| Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins | Q29620720 | ||
| Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? | Q34157847 | ||
| Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study | Q34540479 | ||
| Venice Chart international consensus document on atrial fibrillation ablation. | Q36800522 | ||
| Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study | Q37086807 | ||
| Quality of life and patient-centered outcomes following atrial fibrillation ablation: short- and long-term perspectives to improving care | Q38036333 | ||
| Relationship between the CHADS(2) score and risk of very late recurrences after catheter ablation of paroxysmal atrial fibrillation | Q39642652 | ||
| The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation | Q39899229 | ||
| Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). | Q42923039 | ||
| Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy | Q43612801 | ||
| Symptomatic and asymptomatic atrial fibrillation after pulmonary vein ablation and the impact on quality of life | Q43695551 | ||
| Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study | Q43984938 | ||
| Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up | Q44119179 | ||
| Successful catheter ablation reduces the risk of cardiovascular events in atrial fibrillation patients with CHA2DS2-VASc risk score of 1 and higher | Q48570865 | ||
| The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. | Q51201723 | ||
| Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score ≤3: a long-term outcome study. | Q51426209 | ||
| Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score. | Q53107274 | ||
| Electrophysiological breakthroughs from the left atrium to the pulmonary veins. | Q54030199 | ||
| Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study | Q57260383 | ||
| 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: | Q57627013 | ||
| P433 | issue | 4 | |
| P921 | main subject | catheter ablation | Q436572 |
| Atrial Fibrillation | Q815819 | ||
| thromboembolism | Q891391 | ||
| P304 | page(s) | 499-506 | |
| P577 | publication date | 2015-01-28 | |
| P1433 | published in | Pacing and Clinical Electrophysiology | Q2740882 |
| P1476 | title | Thromboembolic events 7-11 years after catheter ablation of atrial fibrillation | |
| P478 | volume | 38 |
| Q55263071 | 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design |
| Q45059153 | 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation |
| Q46658026 | 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation |
| Q36773643 | Combined catheter ablation for atrial fibrillation and Watchman® left atrial appendage occlusion procedures: Five-year experience |
Search more.